Nifty
Sensex
:
:
24300.10
79981.75
-209.15 (-0.85%)
-520.33 (-0.65%)

Chemicals

Rating :
54/99

BSE: 537253 | NSE: Not Listed

82.65
22-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  84.5
  •  84.5
  •  82.6
  •  84.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  144
  •  12045
  •  101.75
  •  45.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 84.76
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 147.30
  • N/A
  • 1.24

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 73.53%
  • 7.34%
  • 17.79%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 1.34%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.13
  • 6.35
  • 6.83

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.87
  • 8.20
  • 24.71

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.84
  • 107.83
  • 192.12

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.32
  • -
  • 6.47

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.14
  • 1.06
  • 1.36

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.88
  • 7.29
  • 7.50

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
21.31
21.26
0.24%
22.67
25.18
-9.97%
23.70
30.64
-22.65%
22.51
33.41
-32.62%
Expenses
18.64
18.54
0.54%
23.30
23.17
0.56%
22.48
26.57
-15.39%
21.69
26.05
-16.74%
EBITDA
2.67
2.72
-1.84%
-0.63
2.01
-
1.23
4.07
-69.78%
0.82
7.36
-88.86%
EBIDTM
12.54%
12.82%
-2.78%
7.99%
5.17%
13.29%
3.63%
22.02%
Other Income
0.68
0.96
-29.17%
3.13
0.85
268.24%
0.22
1.77
-87.57%
1.19
0.92
29.35%
Interest
1.76
1.17
50.43%
1.44
1.07
34.58%
1.31
1.10
19.09%
1.27
0.82
54.88%
Depreciation
1.43
2.00
-28.50%
1.46
1.67
-12.57%
1.59
1.71
-7.02%
1.61
1.63
-1.23%
PBT
0.16
0.51
-68.63%
-0.39
0.11
-
-1.46
3.04
-
-0.87
5.82
-
Tax
0.01
0.06
-83.33%
-0.19
0.19
-
-0.36
0.91
-
-0.23
1.64
-
PAT
0.15
0.45
-66.67%
-0.20
-0.08
-
-1.10
2.13
-
-0.64
4.18
-
PATM
0.71%
2.12%
-0.89%
-0.31%
-4.63%
6.94%
-2.85%
12.52%
EPS
0.15
0.44
-65.91%
-0.20
-0.08
-
-1.07
2.07
-
-0.63
4.08
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
90.19
110.49
119.16
90.62
70.02
81.20
90.32
101.63
Net Sales Growth
-18.37%
-7.28%
31.49%
29.42%
-13.77%
-10.10%
-11.13%
 
Cost Of Goods Sold
46.38
47.21
48.45
42.71
28.11
28.94
36.02
50.96
Gross Profit
43.81
63.28
70.71
47.92
41.91
52.25
54.31
50.68
GP Margin
48.58%
57.27%
59.34%
52.88%
59.85%
64.35%
60.13%
49.87%
Total Expenditure
86.11
94.53
102.20
85.33
78.22
70.44
76.08
86.60
Power & Fuel Cost
-
9.35
8.90
8.39
9.27
9.53
8.89
6.87
% Of Sales
-
8.46%
7.47%
9.26%
13.24%
11.74%
9.84%
6.76%
Employee Cost
-
14.78
14.19
12.30
13.02
12.77
12.55
10.66
% Of Sales
-
13.38%
11.91%
13.57%
18.59%
15.73%
13.90%
10.49%
Manufacturing Exp.
-
9.86
11.16
8.64
7.91
7.47
7.46
7.31
% Of Sales
-
8.92%
9.37%
9.53%
11.30%
9.20%
8.26%
7.19%
General & Admin Exp.
-
3.73
3.25
2.85
3.38
4.35
4.86
3.35
% Of Sales
-
3.38%
2.73%
3.15%
4.83%
5.36%
5.38%
3.30%
Selling & Distn. Exp.
-
6.29
8.56
5.79
4.64
3.70
4.25
3.66
% Of Sales
-
5.69%
7.18%
6.39%
6.63%
4.56%
4.71%
3.60%
Miscellaneous Exp.
-
3.31
7.68
4.66
11.89
3.68
2.04
3.79
% Of Sales
-
3.00%
6.45%
5.14%
16.98%
4.53%
2.26%
3.73%
EBITDA
4.09
15.96
16.96
5.29
-8.20
10.76
14.24
15.03
EBITDA Margin
4.53%
14.44%
14.23%
5.84%
-11.71%
13.25%
15.77%
14.79%
Other Income
5.22
4.70
2.09
5.58
14.68
0.83
2.23
1.37
Interest
5.78
4.17
3.49
5.31
6.95
6.72
5.38
4.18
Depreciation
6.09
7.01
6.31
6.11
6.13
5.74
4.78
4.33
PBT
-2.56
9.48
9.26
-0.55
-6.60
-0.88
6.31
7.89
Tax
-0.77
2.80
2.84
0.08
-1.64
-0.18
1.82
2.86
Tax Rate
30.08%
29.54%
30.67%
-14.55%
24.85%
20.45%
28.84%
36.25%
PAT
-1.79
6.68
6.42
-0.64
-4.96
-0.69
4.49
5.03
PAT before Minority Interest
-1.79
6.68
6.42
-0.64
-4.96
-0.69
4.49
5.03
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-1.98%
6.05%
5.39%
-0.71%
-7.08%
-0.85%
4.97%
4.95%
PAT Growth
-126.80%
4.05%
-
-
-
-
-10.74%
 
EPS
-1.74
6.49
6.23
-0.62
-4.82
-0.67
4.36
4.88

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
56.00
49.95
43.72
44.60
46.77
47.43
42.91
Share Capital
10.25
10.25
10.25
10.25
10.25
10.25
10.25
Total Reserves
45.74
39.70
33.46
34.34
36.52
37.18
32.65
Non-Current Liabilities
19.31
19.92
23.33
19.36
16.89
26.35
19.45
Secured Loans
5.94
6.63
7.44
3.79
8.89
17.44
12.32
Unsecured Loans
3.08
4.20
7.79
8.24
0.80
0.85
0.46
Long Term Provisions
1.60
2.07
2.11
1.82
1.11
2.01
1.29
Current Liabilities
45.48
39.81
53.51
66.26
74.06
68.42
60.36
Trade Payables
14.75
8.63
12.80
22.55
22.91
17.97
19.67
Other Current Liabilities
6.66
10.74
11.10
10.27
10.91
11.10
7.88
Short Term Borrowings
22.45
19.11
28.67
32.32
39.16
38.58
27.57
Short Term Provisions
1.63
1.33
0.93
1.12
1.09
0.77
5.24
Total Liabilities
120.79
109.68
120.56
130.22
137.72
142.20
122.72
Net Block
70.43
69.97
69.80
69.97
68.83
70.92
59.72
Gross Block
108.29
102.78
96.36
90.67
83.60
80.01
64.03
Accumulated Depreciation
37.86
32.81
26.56
20.70
14.77
9.09
4.31
Non Current Assets
72.68
74.88
72.05
71.18
72.26
73.06
61.90
Capital Work in Progress
0.01
1.75
0.01
0.01
2.47
0.19
0.12
Non Current Investment
0.00
1.03
1.07
0.11
0.11
0.10
0.00
Long Term Loans & Adv.
1.06
1.98
1.11
1.07
0.83
1.84
2.05
Other Non Current Assets
1.18
0.15
0.06
0.02
0.03
0.01
0.00
Current Assets
48.11
34.81
48.51
59.05
65.47
69.14
60.82
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
13.60
11.05
13.73
24.86
16.60
10.13
10.78
Sundry Debtors
28.41
18.89
23.43
23.56
39.24
48.14
38.51
Cash & Bank
3.94
3.46
8.28
5.00
2.69
4.83
3.93
Other Current Assets
2.16
0.66
1.60
2.02
6.94
6.04
7.59
Short Term Loans & Adv.
1.22
0.74
1.47
3.61
4.24
3.25
5.40
Net Current Assets
2.62
-5.00
-5.00
-7.21
-8.59
0.72
0.46
Total Assets
120.79
109.69
120.56
130.23
137.73
142.20
122.72

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
7.47
22.51
16.98
4.31
14.73
5.48
10.79
PBT
9.48
9.26
-0.55
-6.60
-0.88
6.31
7.89
Adjustment
7.37
13.26
8.17
8.85
12.38
9.17
9.03
Changes in Working Capital
-8.01
1.18
9.20
2.16
3.56
-8.55
-4.47
Cash after chg. in Working capital
8.85
23.70
16.83
4.41
15.07
6.93
12.45
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-1.38
-1.19
0.16
-0.10
-0.34
-1.44
-1.66
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-3.40
-4.24
-11.36
-2.52
-2.80
-17.18
-12.85
Net Fixed Assets
-3.77
-8.15
-5.69
-4.62
-5.86
-16.05
Net Investments
1.16
0.04
-0.96
0.00
-0.01
-0.23
Others
-0.79
3.87
-4.71
2.10
3.07
-0.90
Cash from Financing Activity
-3.75
-18.56
-6.42
-1.56
-11.63
11.02
2.23
Net Cash Inflow / Outflow
0.32
-0.29
-0.79
0.23
0.30
-0.67
0.17
Opening Cash & Equivalents
0.27
0.55
1.34
1.11
0.81
1.49
1.32
Closing Cash & Equivalent
0.59
0.27
0.55
1.34
1.11
0.81
1.49

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
51.73
45.84
39.76
40.62
45.61
46.25
41.84
ROA
5.80%
5.58%
-0.51%
-3.70%
-0.49%
3.39%
4.10%
ROE
13.36%
14.63%
-1.55%
-11.23%
-1.47%
9.95%
11.72%
ROCE
16.11%
14.90%
5.26%
0.37%
5.56%
11.96%
13.80%
Fixed Asset Turnover
1.05
1.20
0.97
0.80
0.99
1.27
1.69
Receivable days
78.13
64.82
94.63
163.67
196.41
173.14
129.57
Inventory Days
40.73
37.96
77.71
108.06
60.08
41.78
36.28
Payable days
90.39
80.74
151.07
295.13
101.43
92.46
88.46
Cash Conversion Cycle
28.47
22.03
21.27
-23.39
155.05
122.46
77.39
Total Debt/Equity
0.66
0.73
1.21
1.18
1.18
1.28
1.04
Interest Cover
3.28
3.66
0.90
0.05
0.87
2.17
2.89

News Update:


  • Sunil Healthcare - Quarterly Results
    28th May 2024, 19:13 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.